chr9-35065363-C-G
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP2PP3_ModeratePP5
The NM_007126.5(VCP):c.464G>C(p.Arg155Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R155L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_007126.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCP | NM_007126.5 | c.464G>C | p.Arg155Pro | missense_variant | 5/17 | ENST00000358901.11 | NP_009057.1 | |
VCP | NM_001354927.2 | c.329G>C | p.Arg110Pro | missense_variant | 5/17 | NP_001341856.1 | ||
VCP | NM_001354928.2 | c.329G>C | p.Arg110Pro | missense_variant | 5/17 | NP_001341857.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCP | ENST00000358901.11 | c.464G>C | p.Arg155Pro | missense_variant | 5/17 | 1 | NM_007126.5 | ENSP00000351777.6 | ||
ENSG00000288699 | ENST00000681845.1 | n.*562G>C | non_coding_transcript_exon_variant | 5/5 | ENSP00000505452.1 | |||||
ENSG00000288699 | ENST00000681845.1 | n.*562G>C | 3_prime_UTR_variant | 5/5 | ENSP00000505452.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 01, 2004 | - - |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;C5436279:Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 27, 2022 | Experimental studies have shown that this missense change affects VCP function (PMID: 19506019, 20604808, 26549226). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg155 amino acid residue in VCP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 15034582, 17763460, 19364651). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt VCP protein function. ClinVar contains an entry for this variant (Variation ID: 8472). This missense change has been observed in individuals with Inclusion body myopathy, Paget's disease of the bone, and frontotemporal dementia (PMID: 15034582, 28692196). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with proline, which is neutral and non-polar, at codon 155 of the VCP protein (p.Arg155Pro). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Apr 24, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at